Singapore markets closed
Straits Times Index
3,191.16 +25.98 (+0.82%) Nikkei
26,547.05 +119.40 (+0.45%) Hang Seng
19,950.21 +51.44 (+0.26%) FTSE 100
7,441.55 +23.40 (+0.32%) BTC-USD
29,611.03 -467.31 (-1.55%) CMC Crypto 200
663.17 +420.49 (+173.27%)
BCRX Jan 2023 17.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:16PM EDT. Market open.
| Previous close | 8.16 |
| Open | 8.16 |
| Bid | 8.30 |
| Ask | 9.80 |
| Strike | 17.00 |
| Expiry date | 2023-01-20 |
| Day's range | 8.16 - 8.16 |
| Contract range | N/A |
| Volume | |
| Open interest | 468 |
- Motley Fool
Why BioCryst Stock Lost Nearly 4% of Its Value Today
The biotech whiffs on both revenue and profitability for its first quarter, and indicates more losses are in store.
- Motley Fool
BioCryst Pharmaceuticals (BCRX) Q1 2022 Earnings Call Transcript
Image source: The Motley Fool. BioCryst Pharmaceuticals (NASDAQ: BCRX)Q1 2022 Earnings CallMay 05, 2022, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and thank you for standing by.
- Zacks
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Lags Revenue Estimates
BioCryst (BCRX) delivered earnings and revenue surprises of -2.56% and 1.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
